CapsoVision (CV) Accumulated Expenses (2024 - 2026)
CapsoVision (CV) posted Accumulated Expenses of $2.7 million for Q4 2025, down 3.33% sequentially from $2.8 million in Q3 2025, and up 373.99% YoY from $569000.0 in Q4 2024.
CapsoVision (CV) Accumulated Expenses (2024 - 2026) Analysis & Trends
CapsoVision has reported Accumulated Expenses for 2 years, with the latest figure at $2.7 million in Q4 2025.
- Quarterly Accumulated Expenses rose 373.99% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 373.99% YoY) and the FY2025 annual result came in at $2.7 million, up 373.99% from the prior year.
- Accumulated Expenses declined to $2.7 million in Q4 2025 per CV's latest filing, from $2.8 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $2.8 million in Q3 2025 and troughed at $569000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Dec 31, 2024 | 569,000.00 |